2023 - Research.com Microbiology in United States Leader Award
His primary areas of study are Mycosis, Surgery, Internal medicine, Aspergillosis and Itraconazole. His Mycosis study is associated with Immunology. The study incorporates disciplines such as Respiratory disease, Adverse effect and Posaconazole in addition to Surgery.
His work is dedicated to discovering how Internal medicine, Gastroenterology are connected with Randomized controlled trial and other disciplines. His Aspergillosis research includes elements of Allergic bronchopulmonary aspergillosis, Aspergillus fumigatus, Neutropenia, Intensive care medicine and Voriconazole. His Itraconazole study integrates concerns from other disciplines, such as Amphotericin B, Discontinuation, Ketoconazole, Prior Therapy and Pharmacotherapy.
David A. Stevens mainly focuses on Microbiology, Immunology, Aspergillosis, Mycosis and Aspergillus fumigatus. In his research, In vivo is intimately related to In vitro, which falls under the overarching field of Microbiology. Pharmacology is closely connected to Itraconazole in his research, which is encompassed under the umbrella topic of Aspergillosis.
David A. Stevens interconnects Amphotericin B, Fluconazole and Internal medicine, Chemotherapy in the investigation of issues within Mycosis. His Internal medicine research includes themes of Endocrinology and Ketoconazole. His biological study spans a wide range of topics, including Pseudomonas aeruginosa and Biofilm.
Microbiology, Aspergillus fumigatus, Aspergillus, Aspergillosis and Biofilm are his primary areas of study. The Microbiology study combines topics in areas such as In vitro, Pseudomonas aeruginosa, Bacteria, Antibody and Virulence. His work investigates the relationship between In vitro and topics such as Sporotrichosis that intersect with problems in Itraconazole.
David A. Stevens has included themes like Zoology, Hypoxia, Lung and Transplantation in his Aspergillus fumigatus study. His Aspergillosis research is classified as research in Immunology. His Immunology research integrates issues from Regimen and Cystic fibrosis.
David A. Stevens spends much of his time researching Microbiology, Aspergillus fumigatus, Biofilm, Pseudomonas aeruginosa and Intensive care medicine. His study in Microbiology is interdisciplinary in nature, drawing from both Medical emergency, Outbreak and Internal transcribed spacer. Aspergillus fumigatus is a subfield of Immunology that David A. Stevens investigates.
The various areas that he examines in his Intensive care medicine study include Infectious Disease Medicine, Valley fever and MEDLINE. His research investigates the link between MEDLINE and topics such as Voriconazole that cross with problems in Pharmacology. His Flucytosine study incorporates themes from Itraconazole and Posaconazole.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw;Thomas J. Walsh;J. Peter Donnelly;David A. Stevens.
Clinical Infectious Diseases (2008)
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
Thomas J. Walsh;Elias J. Anaissie;David W. Denning;Raoul Herbrecht.
Clinical Infectious Diseases (2008)
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
S. Ascioglu;J. H. Rex;B. De Pauw;J. E. Bennett.
Clinical Infectious Diseases (2002)
Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America
Thomas F. Patterson;George Richard Thompson;David W. Denning;Jay A. Fishman.
Clinical Infectious Diseases (2016)
Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published Cases
David W. Denning;David A. Stevens.
Clinical Infectious Diseases (1990)
Practice Guidelines for Diseases Caused by Aspergillus
David A. Stevens;David A. Stevens;David A. Stevens;Virginia L. Kan;Virginia L. Kan;Marc A. Judson;Marc A. Judson;Vicki A. Morrison.
Clinical Infectious Diseases (2000)
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach.
Clinical Infectious Diseases (2020)
Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.
Thomas F. Patterson;William R. Kirkpatrick;Mary White;John W. Hiemenz.
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial
Thomas J. Walsh;Issam Raad;Thomas F. Patterson;Pranatharthi Chandrasekar.
Clinical Infectious Diseases (2007)
Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis—State of the Art: Cystic Fibrosis Foundation Consensus Conference
David A. Stevens;Richard B. Moss;Viswanath P. Kurup;Alan P. Knutsen.
Clinical Infectious Diseases (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: